IDH1 and non-Hodgkin lymphoma: In UPN9, we found two mutations in the t-MN sample (IDH1 R132H and SRSF2 P95H), but only the IDH1 R132H was present at the time of NHL diagnosis, probably acting as predisposing factor for the acquisition of the second mutation.